Hans Hartung: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

51

Disease-modifying therapies and infectious risks in multiple sclerosis

Winkelmann, Alexander, Loebermann, Micha, Reisinger, Emil C., Hartung, Hans-Peter, Zettl, Uwe K.

Journal:

Nature Reviews Neurology (formerly Nature Clinical Practice Neurology)

Year:

2016

Language:

english

File:

PDF, 524 KB

english, 2016

52

Macrophage-derived osteopontin induces reactive astrocyte polarization and promotes re-establishment of the blood brain barrier after ischemic stroke

Gliem, Michael, Krammes, Kristina, Liaw, Lucy, van Rooijen, Nico, Hartung, Hans-Peter, Jander, Sebastian

Journal:

Year:

2015

Language:

english

File:

PDF, 1.08 MB

english, 2015

53

Mechanism of Na + Insertion in Alkali Vanadates and Its Influence on Battery Performance

Hartung, Steffen, Bucher, Nicolas, Franklin, Joseph B., Wise, Anna M., Lim, Linda Y., Chen, Han-Yi, Weker, Johanna Nelson, Michel-Beyerle, Maria-E., Toney, Michael F., Srinivasan, Madhavi

Journal:

Advanced Energy Materials

Year:

2016

Language:

english

File:

PDF, 2.69 MB

english, 2016

54

Follow-up nerve conduction studies in CIDP after treatment with IGIV-C: Comparison of patients with and without subsequent relapse

Chin, Russell L., Deng, chunqin, Bril, Vera, Hartung, Hans-Peter, Merkies, Ingemar S. J., Donofrio, Peter D., Van Doorn, Pieter A., Dalakas, Marinos C., Latov, Norman

Journal:

Year:

2015

Language:

english

File:

PDF, 65 KB

english, 2015

55

Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial

van Schaik, Ivo N., van Geloven, Nan, Bril, Vera, Hartung, Hans-Peter, Lewis, Richard A., Sobue, Gen, Lawo, John-Philip, Mielke, Orell, Cornblath, David R., Merkies, Ingemar S. J.

Journal:

Year:

2016

Language:

english

File:

PDF, 772 KB

english, 2016

56

Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis

Hauser, Stephen L., Bar-Or, Amit, Comi, Giancarlo, Giovannoni, Gavin, Hartung, Hans-Peter, Hemmer, Bernhard, Lublin, Fred, Montalban, Xavier, Rammohan, Kottil W., Selmaj, Krzysztof, Traboulsee, Anthon

Journal:

New England Journal of Medicine

Year:

2017

Language:

english

File:

PDF, 285 KB

english, 2017

57

Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis

Montalban, Xavier, Hauser, Stephen L., Kappos, Ludwig, Arnold, Douglas L., Bar-Or, Amit, Comi, Giancarlo, de Seze, Jérôme, Giovannoni, Gavin, Hartung, Hans-Peter, Hemmer, Bernhard, Lublin, Fred, Rammo

Journal:

New England Journal of Medicine

Year:

2017

Language:

english

File:

PDF, 292 KB

english, 2017

58

Impulse Mistuning of Blades and Vanes

Hartung, Andreas, Retze, Ulrich, Hackenberg, Hans-Peter

Journal:

Journal of Engineering for Gas Turbines and Power

Year:

2017

Language:

english

File:

PDF, 1.83 MB

english, 2017

59

Sodium intake and multiple sclerosis activity and progression in BENEFIT

Fitzgerald, Kathryn C, Munger, Kassandra L, Hartung, Hans P, Freedman, Mark S, Montalbán, Xavier, Edan, Gilles, Wicklein, Eva-Maria, Radue, Ernst-Wilhelm, Kappos, Ludwig, Pohl, Christoph, Ascherio, Al

Journal:

Annals of Neurology

Year:

2017

Language:

english

File:

PDF, 1.31 MB

english, 2017

60

Discovery of Molidustat (BAY 85-3934): A Small-Molecule Oral HIF-Prolyl Hydroxylase (HIF-PH) Inhibitor for the Treatment of Renal Anemia

Beck, Hartmut, Jeske, Mario, Thede, Kai, Stoll, Friederike, Flamme, Ingo, Akbaba, Metin, Ergüden, Jens-Kerim, Karig, Gunter, Keldenich, Jörg, Oehme, Felix, Militzer, Hans-Christian, Hartung, Ingo V, T

Journal:

Year:

2018

Language:

english

File:

PDF, 1.96 MB

english, 2018

61

Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension

Kapoor, Raju, Ho, Pei-Ran, Campbell, Nolan, Chang, Ih, Deykin, Aaron, Forrestal, Fiona, Lucas, Nisha, Yu, Bei, Arnold, Douglas L, Freedman, Mark S, Goldman, Myla D, Hartung, Hans-Peter, Havrdová, Eva

Journal:

The Lancet Neurology

Year:

2018

Language:

english

File:

PDF, 339 KB

english, 2018

62

Rig and Engine Validation of the Nonlinear Forced Response Analysis Performed by the Tool OrAgL

Hartung, Andreas, Hackenberg, Hans-Peter, Krack, Malte, Gross, Johann, Heinze, Torsten, Panning-von Scheidt, Lars

Journal:

Journal of Engineering for Gas Turbines and Power

Year:

2018

Language:

english

File:

PDF, 1.83 MB

english, 2018

63

Incidence, management, and outcomes of autoimmune nephropathies following alemtuzumab treatment in patients with multiple sclerosis

Phelps, Richard, Winston, Jonathan A, Wynn, Daniel, Habek, Mario, Hartung, Hans-Peter, Havrdová, Eva Kubala, Markowitz, Glen S, Margolin, David H, Rodriguez, Claudio E, Baker, Darren P, Coles, Alasdai

Journal:

Multiple Sclerosis Journal

Year:

2019

Language:

english

File:

PDF, 861 KB

english, 2019

64

Safety and efficacy of opicinumab in patients with relapsing multiple sclerosis (SYNERGY): a randomised, placebo-controlled, phase 2 trial

Cadavid, Diego, Mellion, Michelle, Hupperts, Raymond, Edwards, Keith R, Calabresi, Peter A, Drulović, Jelena, Giovannoni, Gavin, Hartung, Hans-Peter, Arnold, Douglas L, Fisher, Elizabeth, Rudick, Rich

Journal:

The Lancet Neurology

Year:

2019

Language:

english

File:

PDF, 422 KB

english, 2019

65

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (SUNBEAM): a multicentre, randomised, minimum 12-month, phase 3 trial

Comi, Giancarlo, Kappos, Ludwig, Selmaj, Krzysztof W, Bar-Or, Amit, Arnold, Douglas L, Steinman, Lawrence, Hartung, Hans-Peter, Montalban, Xavier, Kubala Havrdová, Eva, Cree, Bruce A C, Sheffield, Jam

Journal:

The Lancet Neurology

Year:

2019

Language:

english

File:

PDF, 741 KB

english, 2019

66

Safety and efficacy of ozanimod versus interferon beta-1a in relapsing multiple sclerosis (RADIANCE): a multicentre, randomised, 24-month, phase 3 trial

Cohen, Jeffrey A, Comi, Giancarlo, Selmaj, Krzysztof W, Bar-Or, Amit, Arnold, Douglas L, Steinman, Lawrence, Hartung, Hans-Peter, Montalban, Xavier, Kubala Havrdová, Eva, Cree, Bruce A C, Sheffield, J

Journal:

The Lancet Neurology

Year:

2019

Language:

english

File:

PDF, 1.20 MB

english, 2019

67

Learning soft domain constraints in a factor graph model for template-based information extraction

ter Horst, Hendrik, Hartung, Matthias, Cimiano, Philipp, Brazda, Nicole, Müller, Hans Werner, Klinger, Roman

Journal:

Data & Knowledge Engineering

Year:

2019

Language:

english

File:

PDF, 1.16 MB

english, 2019

68

Antitumor activity of methotrexate-albumin conjugates in rats bearing a Walker-256 carcinoma

Andreas Wunder, Gerd Stehle, Hans Herrmann Schrenk, Gernot Hartung, Dieter Ludwig Heene, Wolfgang Maier-Borst, Hannsjörg Sinn

Journal:

International Journal of Cancer

Year:

1998

Language:

english

File:

PDF, 159 KB

english, 1998

69

Usage of vβ3.3 T-cell receptor by myelin basic protein-specific encephalitogenic T-cell lines in the Lewis rat

Andrew Chan, Ralf Gold, Gerhard Giegerich, Thomas Herrmann, Stefan Jung, Klaus V. Toyka, Hans-Peter Hartung

Journal:

Journal of Neuroscience Research

Year:

1999

Language:

english

File:

PDF, 470 KB

english, 1999

70

Microglia and macrophages are major sources of locally produced transforming growth factor-β1 after transient middle cerebral artery occlusion in rats

Elin Lehrmann, Reinhard Kiefer, Thomas Christensen, Klaus V. Toyka, Jens Zimmer, Nils H. Diemer, Hans-Peter Hartung, Bente Finsen

Journal:

Year:

1998

Language:

english

File:

PDF, 1.24 MB

english, 1998

71

Fast multislice T1 and T1sat imaging using a phase acquisition of composite echoes (PACE) technique

Stefan Ropele, Rudolf Stollberger, Peter Kapeller, Hans-Peter Hartung, Franz Fazekas

Journal:

Magnetic Resonance in Medicine

Year:

1999

Language:

english

File:

PDF, 338 KB

english, 1999

72

Estimation of magnetization transfer rates from PACE experiments with pulsed RF saturation

Stefan Ropele, Rudolf Stollberger, Hans-Peter Hartung, Franz Fazekas

Journal:

Journal of Magnetic Resonance Imaging

Year:

2000

Language:

english

File:

PDF, 224 KB

english, 2000

73

Magnetic resonance diffusion tensor imaging for characterizing diffuse and focal white matter abnormalities in multiple sclerosis

Roland Bammer, Michael Augustin, Siegrid Strasser-Fuchs, Thomas Seifert, Peter Kapeller, Rudolf Stollberger, Franz Ebner, Hans-Peter Hartung, Franz Fazekas

Journal:

Magnetic Resonance in Medicine

Year:

2000

Language:

english

File:

PDF, 285 KB

english, 2000

74

The role of B cells and autoantibodies in multiple sclerosis

Juan J. Archelos, Maria K. Storch, Hans-Peter Hartung

Journal:

Annals of Neurology

Year:

2000

Language:

english

File:

PDF, 2.05 MB

english, 2000

75

Patients with active relapsing-remitting multiple sclerosis synthesize antibodies recognizing oligodendrocyte progenitor cell surface protein: Implications for remyelination

Antje Niehaus, Jian Shi, Martina Grzenkowski, Marianne Diers-Fenger, Juan Archelos, Hans-Peter Hartung, Klaus Toyka, Wolfgang Brück, Jacqueline Trotter

Journal:

Annals of Neurology

Year:

2000

Language:

english

File:

PDF, 3.21 MB

english, 2000

76

Reply

Juan J. Archelos, Hans-Peter Hartung

Journal:

Annals of Neurology

Year:

2000

Language:

english

File:

PDF, 106 KB

english, 2000

77

The bradykinesia akinesia incoordination test (BRAIN TEST©), an objective and user-friendly means to evaluate patients with Parkinsonism

Carl Nikolaus Homann, Klaudia Suppan, Karoline Wenzel, Gavin Giovannoni, Gert Ivanic, Susanne Horner, Erwin Ott, Hans Peter Hartung

Journal:

Movement Disorders

Year:

2000

Language:

english

File:

PDF, 86 KB

english, 2000

78

Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon β1a

Frederik Barkhof, Mara Rocca, Gordon Francis, Jan-Hein T. M. van Waesberghe, Bernard M. J. Uitdehaag, Otto R. Hommes, Hans-Peter Hartung, Luca Durelli, Gilles Edan, Oscar Fernández, Pierette Seeldraye

Journal:

Annals of Neurology

Year:

2003

Language:

english

File:

PDF, 130 KB

english, 2003

79

P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy

Wei Xing Yan, Juan J. Archelos, Hans-Peter Hartung, John D. Pollard

Journal:

Annals of Neurology

Year:

2001

Language:

english

File:

PDF, 1.19 MB

english, 2001

80

Viral load determines the B-cell response in the cerebrospinal fluid during human immunodeficiency virus infection

Sabine Cepok, Gloria von Geldern, Thorsten Nolting, Verena Grummel, Rajneesh Srivastava, Dun Zhou, Hans-Peter Hartung, Ortwin Adams, Gabriele Arendt, Bernhard Hemmer

Journal:

Annals of Neurology

Year:

2007

Language:

english

File:

PDF, 481 KB

english, 2007

81

What do we really see when we look at magnetic resonance images?

Massimo Filippi, Hans-Peter Hartung

Journal:

Annals of Neurology

Year:

2007

Language:

english

File:

PDF, 93 KB

english, 2007

82

Toward the development of rational therapies in multiple sclerosis: what is on the horizon?

Bernhard Hemmer, Hans-Peter Hartung

Journal:

Annals of Neurology

Year:

2007

Language:

english

File:

PDF, 343 KB

english, 2007

83

Cerebrospinal fluid of brain trauma patients inhibits in vitro neuronal network function via NMDA receptors

Frauke Otto, Sebastian Illes, Jessica Opatz, Maurice Laryea, Stephan Theiss, Hans-Peter Hartung, Alfons Schnitzler, Mario Siebler, Marcel Dihné

Journal:

Annals of Neurology

Year:

2009

Language:

english

File:

PDF, 1.12 MB

english, 2009

84

Bleak prospects for primary progressive multiple sclerosis therapy: Downs and downs, but a glimmer of hope

Hans-Peter Hartung, Orhan Aktas

Journal:

Annals of Neurology

Year:

2009

Language:

english

File:

PDF, 62 KB

english, 2009

85

Considerations on discontinuing natalizumab for the treatment of multiple sclerosis

Joseph R. Berger, Diego Centonze, Giancarlo Comi, Christian Confavreux, Gary Cutter, Gavin Giovannoni, Ralf Gold, Hans-Peter Hartung, Fred Lublin, Augusto Miravalle, Xavier Montalban, Paul O'Connor, T

Journal:

Annals of Neurology

Year:

2010

Language:

english

File:

PDF, 72 KB

english, 2010

86

Activation of CXCR7 receptor promotes oligodendroglial cell maturation

Peter Göttle, David Kremer, Sebastian Jander, Veysel Ödemis, Jürgen Engele, Hans-Peter Hartung, Patrick Küry

Journal:

Annals of Neurology

Year:

2010

Language:

english

File:

PDF, 1.65 MB

english, 2010

87

Assessment of JC virus DNA in blood and urine from natalizumab-treated patients

Clemens Warnke, Ortwin Adams, Hans-Peter Hartung, Bernd C. Kieseier

Journal:

Annals of Neurology

Year:

2011

Language:

english

File:

PDF, 169 KB

english, 2011

88

The complex world of oligodendroglial differentiation inhibitors

David Kremer, Orhan Aktas, Hans-Peter Hartung, Patrick Küry

Journal:

Annals of Neurology

Year:

2011

Language:

english

File:

PDF, 408 KB

english, 2011

89

Beyond axonal transection: Hippocampal damage in multiple sclerosis

Orhan Aktas, Hans-Peter Hartung

Journal:

Annals of Neurology

Year:

2011

Language:

english

File:

PDF, 59 KB

english, 2011

90

Revised McDonald criteria: The persisting importance of cerebrospinal fluid analysis

Hayrettin Tumani, Florian Deisenhammer, Gavin Giovannoni, Ralf Gold, Hans-Peter Hartung, Bernhard Hemmer, Reinhard Hohlfeld, Markus Otto, Martin Stangel, Brigitte Wildemann, Uwe K. Zettl

Journal:

Annals of Neurology

Year:

2011

Language:

english

File:

PDF, 52 KB

english, 2011

91

Fingolimod treatment for multiple sclerosis Patients What Do We Do with Varicella?

Alexander Winkelmann, Micha Loebermann, Emil C. Reisinger, Hans Peter Hartung, Uwe K. Zettl

Journal:

Annals of Neurology

Year:

2011

Language:

english

File:

PDF, 59 KB

english, 2011

92

The role of macrophages in experimental autoimmune neuritis induced by a P2-Specific T-Cell line

Dr. Kurt Heininger, Bärbel Schäfer, Hans-Peter Hartung, Walter Fierz, Christopher Linington, Klaus V. Toyka

Journal:

Annals of Neurology

Year:

1988

Language:

english

File:

PDF, 639 KB

english, 1988

93

Suppression of experimental autoimmune neuritis by the oxygen radical scavengers superoxide dismutase and catalase

Dr. Hans-Peter Hartung, Bärbel Schäfer, Kurt Heininger, Klaus V. Toyka

Journal:

Annals of Neurology

Year:

1988

Language:

english

File:

PDF, 1014 KB

english, 1988

94

The role of interferon-gamma in the pathogenesis of experimental autoimmune disease of the peripheral nervous system

Hans-Peter Hartung, Bärbel Schäfer, Peter H. Van Der Meide, Walter Fierz, Kurt Heininger, Klaus V. Toyka

Journal:

Annals of Neurology

Year:

1990

Language:

english

File:

PDF, 3.30 MB

english, 1990

95

T-Cell and macrophage activation in experimental autoimmune neuritis and Guillain-Barré syndrome

Hans-Peter Hartung, Klaus V. Toyka

Journal:

Annals of Neurology

Year:

1990

Language:

english

File:

PDF, 1.56 MB

english, 1990

96

Macrophages but not schwann cells express ia antigen in experimental autoimmune neuritis

Beate Schmidt, Dr Guido Stoll, Hans-Peter Hartung, Kurt Heininger, Bärbel Schäfer, Klaus V. Toyka

Journal:

Annals of Neurology

Year:

1990

Language:

english

File:

PDF, 952 KB

english, 1990

97

Serum interleukin-2 concentrations in Guillain-Barré syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: Comparison with other neurological diseases of presumed immunopathogenesis

Dr. Hans-Peter Hartung, Karlheinz Reiners, Beate Schmidt, Guido Stoll, Klaus V. Toyka

Journal:

Annals of Neurology

Year:

1991

Language:

english

File:

PDF, 562 KB

english, 1991

98

Presence of the terminal complement complex (C5b-9) precedes myelin degradation in immune-mediated demyelination of the rat peripheral nervous system

Dr. Guido Stoll, Beate Schmidt, Sebastian Jander, Klaus V. Toyka, Hans-Peter Hartung

Journal:

Annals of Neurology

Year:

1991

Language:

english

File:

PDF, 1.05 MB

english, 1991

99

Reactive nitrogen intermediates: Effector molecules of immune-mediated inflammatory nervous system disorders?

Hans-Peter Hartung, Jürgen Zielasek, Klaus V. Toyka, Ted M. Dawson

Journal:

Annals of Neurology

Year:

1993

Language:

english

File:

PDF, 119 KB

english, 1993

100

Immune-mediated demyelination

Dr., MD Hans-Peter Hartung

Journal:

Annals of Neurology

Year:

1993

Language:

english

File:

PDF, 534 KB

english, 1993

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@z-lib.do

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски